Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients
1 other identifier
interventional
140
1 country
6
Brief Summary
This study aims to compare nutritional outcomes in terms of percentage of weight gain between a new planted-based high-energy ONS and a standard high-energy ONS with animal protein (cow's mil protein) in patients at malnutrition according to Global Leadership Initiative on Malnutrition (GLIM) criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Aug 2023
Shorter than P25 for phase_4
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 9, 2023
CompletedFirst Submitted
Initial submission to the registry
September 14, 2023
CompletedFirst Posted
Study publicly available on registry
September 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedSeptember 26, 2023
September 1, 2023
10 months
September 14, 2023
September 20, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change in weight
Change in weight percentage
Changes between baseline and final visit (12 weeks).
Improvement in nutritional status
Improvement in nutritional status according to the GLIM criteria. A change in classification category from grade 2 of malnutrition to grade 1 or not meet GLIM criteria, as well as a change from grade 1 to not meet GLIM criteria are considered an improvement.
From the baseline to the final visit (12 weeks)
Secondary Outcomes (5)
Change in muscle strength
From the baseline to final visit (12 weeks)
Change in calf circumference
From baseline to final visit (12 week)
Percentage of compliance
During the study follow up
Changes in the gastrointestinal symptom scale (GSRS)
From the baseline to final visit (12 week)
ONS Satisfaction
Final visit (12 week)
Study Arms (2)
Fortimel Energy
ACTIVE COMPARATORControl: high-energy ONS 1.5 Kcal/m 200ml for 90 days
Fortimel PlantBased
EXPERIMENTALIntervention: high-energy ONS 1.5 Kcal/m 200ml for 90 days
Interventions
Eligibility Criteria
You may qualify if:
- Patients ≥ 18 years old
- Malnourished patients according to GLIM criteria
- Patients with a high energy requirement (1.5kcal/ml) requiring the intake of 2 bottles of ONS per day for at least 12 weeks
- Patients presenting any of the following clinical situations:
- Elderly patients requiring oral nutritional support
- Patients with digestive pathology including but not restricted to inflammatory bowel disease, short bowel syndrome, pancreatitis, without active malabsorption and maldigestion.
- Chronic diseases such as COPD, mild to moderate renal disease, HIV
- Oncologic patients with Eastern Cooperative Oncology Group (ECOG) 0-1
- Patients who have given their consent to participate
- Patients who, in the opinion of the physician, have the capacity to answer the study questionnaires themselves or their caregivers
You may not qualify if:
- Patients who need ONS due to surgical or acute illness\*
- Patients with known intolerance or allergy to cow's milk, soya or peas
- Patients with hyperthyroidism. Patients with uncontrolled hypothyroidism
- Uncontrolled diabetic patients (HbA1c \>8%)
- Patients requiring enteral nutrition by tube or ostomy
- Patients with moderate and serious renal insufficiency \< 30ml/min/1,73 m2
- Patients who have value creatinine:
- ,70 mg/dl - 150,31umol/L Men
- ,50 mg/dl - 132,63umol/L Women
- Patients with levels of haemoglobin \<10 g/dl, transferrin \<150 mg /dl
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Hospital Universitario de Basurto
Bilbao, 48013, Spain
Hospital Universitario Reina Sofía
Córdoba, 14004, Spain
Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria, 35010, Spain
Hospital Universitario de Móstoles
Madrid, 28935, Spain
Hospital Universitario Virgen del Rocío
Seville, 41013, Spain
Hospital Clínico Valladolid
Valladolid, 47003, Spain
Related Publications (1)
Iglesias Hernandez NC, Ramos Carrasco A, De Luis Roman DA, de Pablos-Velasco PL, Calanas Continente A, Rodriguez Soto MJ, Lopez-Gomez JJ, Comi-Diaz C, Garcia-Rey S, Perez-Rambla C, Garcia-Luna PP. Effect of a new plant-based high-energy oral nutritional supplement in adult malnourished patients: an open-label, randomized clinical trial. Front Nutr. 2025 Nov 20;12:1667954. doi: 10.3389/fnut.2025.1667954. eCollection 2025.
PMID: 41356829DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2023
First Posted
September 26, 2023
Study Start
August 9, 2023
Primary Completion
May 31, 2024
Study Completion
May 31, 2024
Last Updated
September 26, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share